Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

56.51
Delayed Data
As of Jan 18
 +0.10 / +0.18%
Today’s Change
32.83
Today|||52-Week Range
56.74
+5.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
AssetsCash2.7B2.4B3.3B3.0B
 
 
 
 
 
Short Term Investment Cash652.0M-332.9M507.0M-111.8M
 
 
 
 
 
Cash & Short Term Investments3.0B2.6B3.5B3.4B
 
 
 
 
 
 
ReceivablesReceivables3.4B3.2B2.8B2.8B
 
 
 
 
 
 
InventoriesInventories2.0B2.2B2.3B2.4B
 
 
 
 
 
 
Current AssetsOther Current Assets0.000.00434.1M418.1M
 
 
 
Current Assets8.5B8.0B9.0B9.1B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross8.2B------
 
 
Depreciation-3.9B------
 
 
Intangible Assets385.0M398.6M406.0M415.4M
 
 
 
 
 
Other Assets385.0M398.6M406.0M415.4M
 
 
 
 
 
Total Assets13.8B13.6B15.0B15.6B
 
 
 
 
 
 
LiabilitiesAccounts Payable852.7M544.0M653.0M719.6M
 
 
 
 
 
Short Term Debt32.5M88.2M258.2M41.3M
 
 
 
 
 
Accrued Expenses986.3M------
 
 
Other Current Liabilities4.6B5.8B5.2B5.5B
 
 
 
 
 
Other Liabilities6.7B7.0B6.7B7.2B
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-378.7M-380.4M-267.7M-235.6M
 
 
 
 
 
Other Liabilities0.000.000.000.00
 
 
Total Liabilities7.4B7.8B7.6B8.1B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity6.4B5.8B7.4B7.5B
 
 
 
 
 
Total Shareholder Equity6.4B5.8B7.4B7.5B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.0B2.0B2.0B2.0B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.